Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration. Intracoronary (IC) bolus application of abciximab causes very high...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wolters Kluwer Medknow Publications 2013-01-01
Serier:	Heart Views
Fag:	Abciximab acute coronary artery disease intracoronary intravenous stent thrombosis tirofiban
Online adgang:	http://www.heartviews.org/article.asp?issn=1995-705X;year=2013;volume=14;issue=2;spage=62;epage=67;aulast=Balghith
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!